CenterWatch’s Flagship Publication

The CenterWatch Monthly

Launched 15 years ago to provide proprietary data and information about the thenbudding clinical trials industry

The CenterWatch Monthly: Niche

• The publication’s audience is comprised of busy clinical research professionals, ranging from site level to C-level at biopharmaceutical companies and contract research organizations.

• Through featuring a broad array of topics, including in-depth coverage of global markets, proprietary survey results, and trends in drug development that affect sites, IRBs, CROs and biopharmaceutical companies, the publication meets our audience’s needs.

The CenterWatch Monthly: Landscape

• Covers any issue or trend that relates to the clinical research industry, from sizing country and regional markets to site-CRO relationships to regulatory issues faced by IRBs

• Provides both the novice and the veteran reader with knowledge that makes them better able to carry out their job functions and creates community

• Includes comprehensive and engaging features, using expert interviews and proprietary data that offer readers a thorough understanding of the clinical trials industry

The CenterWatch Monthly: Meets Pharma’s Needs

• Benchmarking: the newsletter is the only objective source available to pharmaceutical companies that measures the quality of the critical site-sponsor relationship.

• Context: CenterWatch editors conduct in-depth interviews on any topic featured and give meaningful context to any activity in the clinical research space.

• Community: Industry professionals read the newsletter to be aware of what topics are being discussed and to join the discussion.

The CenterWatch Monthly Editorial Team: Uniquely Qualified

Trusted, Industry Experts• Reported on the clinical research industry since 1994• Lengthy experience covering the industry makes

them uniquely qualified to recognize trends, analyze proprietary data, and share the most pertinent news with readers

• Vast network of industry experts eager to share their insights with a neutral, trusted publication

• Many readers have relied on the newsletter to run their business, learn more about the industry, and help create internal and industry conference presentations